Actively Recruiting
Evaluation of VasQ External Support Implant Versus Standard Care for End-to-Side Arteriovenous Fistula in Dialysis Patients
Led by Laminate Medical Technologies · Updated on 2026-11-04
300
Participants Needed
13
Research Sites
39 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial to evaluate the VasQ external support implant used for arteriovenous fistulas created for dialysis access. The study aims to compare the time to achieving a clinically functional arteriovenous fistula AVF when supported by VasQ versus standard care in patients with end stage renal disease. Participants are randomly assigned to one of two groups the treatment arm, receiving an end-to-side fistula supported with the VasQ device, and the control arm, receiving a standard end-to-side fistula without support. The study evaluates the performance of the VasQ device as compared to standard care. The primary endpoint is assessed at 6 months after the fistula creation procedure, with further follow-up continuing up to 12 months post-procedure. During the study, participants will undergo fistula creation surgery and regular follow-up visits over a 12-month period to assess fistula functional success. Researchers will monitor the time it takes for the AVF to become clinically functional and evaluate the safety and outcomes related to the VasQ device and standard care procedures. The total participation duration includes the initial procedure and scheduled follow-ups to 12 months after fistula creation.
CONDITIONS
Brief Title
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
Research Team
G
Galit Itzhaki
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here